SAR650984, a CD38 Monoclonal Antibody, for Patients with Selected CD38+ Hematologic Cancers


SAR650984, a CD38 Monoclonal Antibody, for Patients with Selected CD38+ Hematologic Cancers
Slides from a presentation at ASH 2013 and transcribed comments from a recent interview with Rafael Fonseca, MD (2/14/14)
Martin TG et al. SAR650984, a CD38 monoclonal antibody in patients with selected CD38+ hematological malignancies — Data from a dose-escalation Phase I study. Proc ASH 2013;Abstract 284.

Dr Fonseca is Getz Family Professor of Cancer and Chair of the Department of Internal Medicine at the Mayo Clinic Arizona in Scottsdale, Arizona.